E-LIB Suche - Ergebnisse für: Wagener†, Jeffrey S.

1

Recombinant Human Deoxyribonuclease I:

, In: Pharmaceutical Biotechnology,

Lazarus, Robert A. ; Wagener, Jeffrey S. - p. 515-530 , 2024

Link: https://doi.org/10.1007/..

2

Corrigendum to FEV1 Variability Helps Identify Patients wit..:

Morgan, Wayne J. ; VanDevanter, Donald R. ; Pasta, David J....
The Journal of Pediatrics. 255 (2023) - p. 265 , 2023

Link: https://doi.org/10.1016/..

3

Epidemiologic Study of Cystic Fibrosis: 25 years of observa..:

Konstan, Michael W. ; Pasta, David J. ; VanDevanter, Donald R....
Pediatric Pulmonology. 56 (2021) 5 - p. 823-836 , 2021

Link: https://doi.org/10.1002/..

4

Lung function changes before and after pulmonary exacerbati..:

Wagener, Jeffrey S. ; VanDevanter, Donald R. ; Konstan, Michael W....
Pediatric Pulmonology. 55 (2019) 3 - p. 828-834 , 2019

Link: https://doi.org/10.1002/..

5

Recombinant Human Deoxyribonuclease I:

, In: Pharmaceutical Biotechnology,

Lazarus, Robert A. ; Wagener†, Jeffrey S. - p. 471-488 , 2019

Link: https://doi.org/10.1007/..

6

Pulmonary exacerbations and acute declines in lung function..:

Wagener, Jeffrey S. ; Williams, Michael J. ; Millar, Stefanie J....
Journal of Cystic Fibrosis. 17 (2018) 4 - p. 496-502 , 2018

Link: https://doi.org/10.1016/..

7

Lung function decline is delayed but not decreased in patie..:

Wagener, Jeffrey S. ; Millar, Stefanie J. ; Mayer-Hamblett, Nicole...
Journal of Cystic Fibrosis. 17 (2018) 4 - p. 503-510 , 2018

Link: https://doi.org/10.1016/..

8

Recovery of lung function following a pulmonary exacerbatio..:

Flume, Patrick A. ; Wainwright, Claire E. ; Elizabeth Tullis, D....
Journal of Cystic Fibrosis. 17 (2018) 1 - p. 83-88 , 2018

Link: https://doi.org/10.1016/..

9

Comparison of FEV1 reference equations for evaluating a cys..:

Konstan, Michael W. ; Wagener, Jeffrey S. ; VanDevanter, Donald R....
Pediatric Pulmonology. 52 (2017) 8 - p. 1013-1019 , 2017

Link: https://doi.org/10.1002/..

10

BMI fails to identify poor nutritional status in stunted ch..:

Konstan, Michael W. ; Pasta, David J. ; Wagener, Jeffrey S...
Journal of Cystic Fibrosis. 16 (2017) 1 - p. 158-160 , 2017

Link: https://doi.org/10.1016/..

11

Forced Expiratory Volume in 1 Second Variability Helps Iden..:

Morgan, Wayne J. ; VanDevanter, Donald R. ; Pasta, David J....
The Journal of Pediatrics. 169 (2016) - p. 116-121.e2 , 2016

Link: https://doi.org/10.1016/..

12

Pulmonary function outcomes for assessing cystic fibrosis c..:

Wagener, Jeffrey S. ; Elkin, Eric P. ; Pasta, David J....
Journal of Cystic Fibrosis. 14 (2015) 3 - p. 376-383 , 2015

Link: https://doi.org/10.1016/..

13

Liver Involvement in the Hispanic Population of North Ameri..:

Wagener, Jeffrey S. ; Woo, Marlyn S. ; Pasta, David J....
Journal of Pediatric Gastroenterology and Nutrition. 59 (2014) 4 - p. 476-479 , 2014

Link: https://doi.org/10.1097/..

14

Probability of Treatment Following Acute Decline in Lung Fu..:

Morgan, Wayne J. ; Wagener, Jeffrey S. ; Yegin, Ashley...
The Journal of Pediatrics. 163 (2013) 4 - p. 1152-1157.e2 , 2013

Link: https://doi.org/10.1016/..

15

Clinical use of tobramycin inhalation solution (TOBI®) show..:

Konstan, Michael W. ; Wagener, Jeffrey S. ; Pasta, David J...
Pediatric Pulmonology. 49 (2013) 6 - p. 529-536 , 2013

Link: https://doi.org/10.1002/..